The seroprevalence of neutralizing antibody against Dengue virus in health care workers
Not Applicable
- Conditions
- Dengue fever riskDenguePRNTNeutralizing antibodySeroprevalenceSeroepidemiologySerological studyBangkokadultshealthcare workers
- Registration Number
- TCTR20160303002
- Lead Sponsor
- Sanofi Pasteur, Thailand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Enrolling by invitation
- Sex
- All
- Target Recruitment
- 402
Inclusion Criteria
Medical personnel who underwent a medical examination in the year 2015 at Queen Sirikit National Institute of Child Health, and voluntarily join the study
Exclusion Criteria
Who did not provided informed consent to a blood test
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method proportion of protective DF antibody Upon enrollment Plaque reduction neutralization test for Dengue fever
- Secondary Outcome Measures
Name Time Method Predictors of protective antibibody Upon enrollment age, residencial area